Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Results HEXB is an unfavorable indicator which facilitates the regulation of GBM cell glycolysis associated with TAMs To characterize metabolic promoting signaling in grade IV glioma with divergent IDH1 status, we enrolled grade IV glioma samples from four glioma RNA-seq cohorts (CMU cohort n = 30, CGGA325 cohort n = 139, CGGA693 cohort n = 239, TCGA cohort n = 148
The insurance company will review the information and determine whether it will cover the medicine
2014 Jan 1;3(2):134
Key of Benefits
US$ 26.30
US$ 26.87
US$ 20.50
US$ 25.43
